Rocket Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $330.4M
Liabilities Breakdown FY2025
Total Liabilities: $53.2M
Asset Breakdown
Total Assets: $330.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $77.6M | 23.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $28.2M | 8.5% |
| Goodwill | $39.2M | 11.8% |
| Intangible Assets | $25.2M | 7.6% |
| Other Assets | $160.4M | 48.5% |
Liabilities Breakdown
Total Liabilities: $53.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $53.2M | 100.0% |